Micro Cap Growth Fund
Daily price w/o sales charge as of 09/22/2021
$18.65
$0.35
YTD Returns w/o sales charge as of 09/22/2021
4.19%
Overall Morningstar RatingsSmall Growth
as of 08/31/2021
Morningstar rated the Lord Abbett Micro Cap Growth Fund class A share 4, 5 and 5 stars among 575, 506 and 380 Small Growth Funds for the overall rating and the 3, 5 and 10 year periods ended 8/31/2021, respectively.
Please click here for performance current to the most recent quarter-end and month-end.
Summary
Summary
Fund Basicsas of 08/31/2021
- Total Net Assets
- $403.29 M
- Inception Date
- 05/01/2000
- Dividend Frequency
- Annually
- Fund Expense Ratio
- 1.33%
- Number of Holdings
- 83
- Minimum Initial Investment
- $1,500+
Fund Expense Ratio :
1.33%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | 7.71% | 49.07% | 25.77% | 30.30% | 22.34% | 12.45% |
| Lipper Category Avg. Small-Cap Growth Funds | 13.01% | 40.06% | 16.02% | 19.06% | 15.33% | - |
| Russell Microcap® Growth Index | 15.27% | 45.77% | 12.98% | 16.07% | 14.20% | - |
| w/ sales charge | 1.53% | 40.49% | 23.31% | 28.76% | 21.62% | 12.14% |
Fund Expense Ratio :
1.33%
Fund Expense Ratio :
1.33%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | 12.12% | 80.00% | 31.67% | 33.85% | 20.92% | 12.77% |
| Lipper Category Avg. Small-Cap Growth Funds | 11.44% | 53.11% | 18.72% | 20.24% | 13.67% | - |
| Russell Microcap® Growth Index | 20.57% | 65.78% | 17.29% | 18.82% | 13.01% | - |
| w/ sales charge | 5.69% | 69.69% | 29.11% | 32.28% | 20.21% | 12.45% |
Fund Expense Ratio :
1.33%
Returns with sales charges reflect a maximum sales charge of 5.75%.
The performance quoted represents past performance, which is no indication of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost. Therefore, there can be no assurance for future results.
TEN LARGEST HOLDINGS as of 08/31/2021View Portfolio
| Holding | Assets |
|---|---|
| Calix Inc | 2.9% |
| Shyft Group Inc/The | 2.7% |
| Sprout Social Inc | 2.7% |
| Axonics Inc | 2.6% |
| Agilysys Inc | 2.5% |
| Sonos Inc | 2.0% |
| Cerence Inc | 1.9% |
| OrthoPediatrics Corp | 1.9% |
| Gentherm Inc | 1.8% |
| Celsius Holdings Inc | 1.7% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 08/31/2021View Portfolio
| Sector | Weighting |
|---|
| Sector | Weighting |
|---|---|
| Communication Services | |
| Real Estate | |
| Utilities | |
| Not Classified | |
| Consumer Discretionary | |
| Consumer Staples | |
| Energy | |
| Financials | |
| Health Care | |
| Industrials | |
| Information Technology | |
| Materials |
INVESTMENT TEAM
Your Representative
To contact your representative, enter your zip code and select your channel below.
Performance
Performance
Fund Expense Ratio :
1.33%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | 7.71% | 49.07% | 25.77% | 30.30% | 22.34% | 12.45% |
| Lipper Category Avg. Small-Cap Growth Funds | 13.01% | 40.06% | 16.02% | 19.06% | 15.33% | - |
| Russell Microcap® Growth Index | 15.27% | 45.77% | 12.98% | 16.07% | 14.20% | - |
| w/ sales charge | 1.53% | 40.49% | 23.31% | 28.76% | 21.62% | 12.14% |
Fund Expense Ratio :
1.33%
Fund Expense Ratio :
1.33%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | 12.12% | 80.00% | 31.67% | 33.85% | 20.92% | 12.77% |
| Lipper Category Avg. Small-Cap Growth Funds | 11.44% | 53.11% | 18.72% | 20.24% | 13.67% | - |
| Russell Microcap® Growth Index | 20.57% | 65.78% | 17.29% | 18.82% | 13.01% | - |
| w/ sales charge | 5.69% | 69.69% | 29.11% | 32.28% | 20.21% | 12.45% |
Fund Expense Ratio :
1.33%
Returns with sales charges reflect a maximum sales charge of 5.75%.
The performance quoted represents past performance, which is no indication of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost. Therefore, there can be no assurance for future results.
| Year | Fund Returns | Russell Microcap® Growth Index |
|---|
| 2020 | 79.42% | 40.13% |
| 2019 | 34.57% | 23.33% |
| 2018 | 2.74% | -14.18% |
| 2017 | 38.43% | 16.65% |
| 2016 | 2.07% | 6.86% |
| 2015 | -6.38% | -3.85% |
| 2014 | 10.83% | 4.30% |
| 2013 | 78.53% | 52.84% |
| 2012 | 2.35% | 15.17% |
| 2011 | -5.87% | -8.42% |
| 2010 | 33.77% | - |
| 2009 | 52.61% | - |
| 2008 | -46.45% | - |
| 2007 | 22.76% | - |
| 2006 | 25.37% | - |
| 2005 | 2.55% | - |
| 2004 | 25.89% | - |
| 2003 | 49.34% | - |
| 2002 | -30.97% | - |
| 2001 | 16.96% | - |
| Year | Q1 | Q2 | Q3 | Q4 | Yearly Returns |
|---|
| 2021 | 12.29% | -0.15% | - | - | 4.19% |
| 2020 | -24.28% | 47.61% | 17.48% | 36.65% | 79.42% |
| 2019 | 22.67% | 7.47% | -13.91% | 18.57% | 34.57% |
| 2018 | 5.24% | 15.77% | 10.08% | -23.39% | 2.74% |
| 2017 | 9.00% | 8.12% | 13.61% | 3.39% | 38.43% |
| 2016 | -13.70% | 6.01% | 14.49% | -2.55% | 2.07% |
| 2015 | 7.33% | 4.15% | -16.30% | 0.06% | -6.38% |
| 2014 | 7.92% | -6.53% | -6.55% | 17.58% | 10.83% |
| 2013 | 21.83% | 15.00% | 17.29% | 8.65% | 78.53% |
| 2012 | 17.67% | -9.76% | 1.32% | -4.87% | 2.35% |
| 2011 | 4.82% | 0.11% | -21.90% | 14.86% | -5.87% |
| 2010 | 6.60% | -8.74% | 15.08% | 19.49% | 33.77% |
| 2009 | -0.95% | 31.46% | 13.47% | 3.29% | 52.61% |
| 2008 | -23.22% | 4.46% | -5.93% | -29.02% | -46.45% |
| 2007 | 5.64% | 9.81% | 4.01% | 1.76% | 22.76% |
| 2006 | 17.15% | -9.83% | 1.22% | 17.25% | 25.37% |
| 2005 | -9.50% | 5.88% | 6.91% | 0.10% | 2.55% |
| 2004 | 12.33% | 1.65% | -11.11% | 24.03% | 25.89% |
| 2003 | -3.55% | 27.29% | 11.68% | 8.93% | 49.34% |
| 2002 | -0.18% | -12.74% | -21.79% | 1.33% | -30.97% |
| 2001 | 2.34% | 12.03% | -21.11% | 29.32% | 16.96% |
| 2000 | - | - | -4.83% | -19.30% | -30.76% |
Performance is shown for each quarter and each calendar year. Past performance is no guarantee of future results.
Growth of $10,000 as of 07/31/2021
The chart begins on the Fund's inception date of 05/01/2000.
Based on a hypothetical Class A share investment of $10,000 on 05/01/2000 without sales charge and includes the reinvestment of all distributions.
NAV Historical Prices
| Date | Net Asset Value |
|---|
Portfolio
Portfolio
| Holding | Sector | Assets |
|---|
| Calix Inc | Information Technology | 2.9% |
| Shyft Group Inc/The | Industrials | 2.7% |
| Sprout Social Inc | Information Technology | 2.7% |
| Axonics Inc | Health Care | 2.6% |
| Agilysys Inc | Information Technology | 2.5% |
| Sonos Inc | Consumer Discretionary | 2.0% |
| Cerence Inc | Information Technology | 1.9% |
| OrthoPediatrics Corp | Health Care | 1.9% |
| Gentherm Inc | Consumer Discretionary | 1.8% |
| Celsius Holdings Inc | Consumer Staples | 1.7% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
| Holding | Sector | Assets |
|---|
| Calix Inc | Information Technology | 2.9% |
| Agilysys Inc | Information Technology | 2.5% |
| Axonics Inc | Health Care | 2.3% |
| Shyft Group Inc/The | Industrials | 2.2% |
| Sprout Social Inc | Information Technology | 2.0% |
| Cerence Inc | Information Technology | 1.9% |
| Ichor Holdings Ltd | Information Technology | 1.9% |
| OrthoPediatrics Corp | Health Care | 1.7% |
| Gentherm Inc | Consumer Discretionary | 1.7% |
| Sonos Inc | Consumer Discretionary | 1.7% |
| CryoPort Inc | Health Care | 1.7% |
| Rambus Inc | Information Technology | 1.7% |
| Rigel Pharmaceuticals Inc | Health Care | 1.6% |
| Turning Point Brands Inc | Consumer Staples | 1.6% |
| Ooma Inc | Communication Services | 1.6% |
| Ameresco Inc | Industrials | 1.6% |
| Krystal Biotech Inc | Health Care | 1.6% |
| SI-BONE Inc | Health Care | 1.6% |
| Intra-Cellular Therapies Inc | Health Care | 1.5% |
| Criteo SA | Communication Services | 1.5% |
| Green Brick Partners Inc | Consumer Discretionary | 1.5% |
| Container Store Group Inc/The | Consumer Discretionary | 1.5% |
| Montrose Environmental Group Inc | Industrials | 1.5% |
| LGI Homes Inc | Consumer Discretionary | 1.4% |
| Celsius Holdings Inc | Consumer Staples | 1.4% |
| CareDx Inc | Health Care | 1.4% |
| Sleep Number Corp | Consumer Discretionary | 1.4% |
| Telos Corp | Information Technology | 1.4% |
| Chart Industries Inc | Industrials | 1.4% |
| CEVA Inc | Information Technology | 1.3% |
| Bancorp Inc/The | Financials | 1.2% |
| Protagonist Therapeutics Inc | Health Care | 1.2% |
| Citi Trends Inc | Consumer Discretionary | 1.2% |
| Malibu Boats Inc | Consumer Discretionary | 1.1% |
| Quanterix Corp | Health Care | 1.1% |
| Domo Inc | Information Technology | 1.1% |
| NanoString Technologies Inc | Health Care | 1.1% |
| Avid Technology Inc | Information Technology | 1.1% |
| Silvergate Capital Corp | Financials | 1.1% |
| Health Catalyst Inc | Health Care | 1.1% |
| Willdan Group Inc | Industrials | 1.1% |
| Cardlytics Inc | Information Technology | 1.1% |
| OSI Systems Inc | Information Technology | 1.0% |
| Central Garden & Pet Co | Consumer Staples | 1.0% |
| elf Beauty Inc | Consumer Staples | 1.0% |
| Rush Enterprises Inc | Industrials | 1.0% |
| Kforce Inc | Industrials | 1.0% |
| Zuora Inc | Information Technology | 1.0% |
| Evoqua Water Technologies Corp | Industrials | 1.0% |
| Pulmonx Corp | Health Care | 1.0% |
| Myovant Sciences Ltd | Health Care | 0.9% |
| nLight Inc | Information Technology | 0.9% |
| Atlas Air Worldwide Holdings Inc | Industrials | 0.9% |
| Piper Sandler Cos | Financials | 0.9% |
| Shockwave Medical Inc | Health Care | 0.9% |
| Impinj Inc | Information Technology | 0.8% |
| Trupanion Inc | Financials | 0.8% |
| Eventbrite Inc | Communication Services | 0.8% |
| Westport Fuel Systems Inc | Industrials | 0.8% |
| Rocket Pharmaceuticals Inc | Health Care | 0.8% |
| Curis Inc | Health Care | 0.8% |
| Treace Medical Concepts Inc | Health Care | 0.8% |
| HyreCar Inc | Industrials | 0.8% |
| Hydrofarm Holdings Group Inc | Industrials | 0.7% |
| NeuroPace Inc | Health Care | 0.7% |
| Karuna Therapeutics Inc | Health Care | 0.7% |
| Xenon Pharmaceuticals Inc | Health Care | 0.7% |
| Children's Place Inc/The | Consumer Discretionary | 0.7% |
| Inari Medical Inc | Health Care | 0.7% |
| MacroGenics Inc | Health Care | 0.7% |
| Outset Medical Inc | Health Care | 0.6% |
| TG Therapeutics Inc | Health Care | 0.6% |
| Castle Biosciences Inc | Health Care | 0.6% |
| Pliant Therapeutics Inc | Health Care | 0.6% |
| Beam Therapeutics Inc | Health Care | 0.6% |
| Lindblad Expeditions Holdings Inc | Consumer Discretionary | 0.5% |
| Trillium Therapeutics Inc | Health Care | 0.5% |
| Monarch Casino & Resort Inc | Consumer Discretionary | 0.5% |
| Turning Point Therapeutics Inc | Health Care | 0.5% |
| MarineMax Inc | Consumer Discretionary | 0.5% |
| Honest Co Inc/The | Consumer Staples | 0.5% |
| Johnson Outdoors Inc | Consumer Discretionary | 0.4% |
| Insmed Inc | Health Care | 0.4% |
| Akoya Biosciences Inc | Health Care | 0.4% |
| Verastem Inc | Health Care | 0.4% |
| Syndax Pharmaceuticals Inc | Health Care | 0.4% |
| IMAX Corp | Communication Services | 0.4% |
| AssetMark Financial Holdings Inc | Financials | 0.4% |
| Raven Industries Inc | Industrials | 0.3% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 08/31/2021
| Sector | Weighting | Fund Change from Previous Quarter |
|---|
| Sector | Weighting | Fund Change from Previous Quarter |
|---|---|---|
| Communication Services |
 0.5%
|
|
| Real Estate | 0.0% | |
| Utilities | 0.0% | |
| Not Classified | 0.0% | |
| Consumer Discretionary |
2.0%
|
|
| Consumer Staples |
0.4%
|
|
| Energy | 0.0% | |
| Financials |
1.5%
|
|
| Health Care |
4.0%
|
|
| Industrials | 0.0% | |
| Information Technology |
0.1%
|
|
| Materials | 0.0% |
Portfolio Details as of 08/31/2021
- Total Net Assets
- $403.29 M
- Number of Holdings
- 83
- Weighted Average Market Cap.
- 2.4 B
- P/B Ratio
- 5.0x
- P/E Ratio
- 17.8x
To view definitions for the above Portfolio Details, Click here.
P/B Ratio - A ratio that helps determine whether a stock is undervalued or overvalued. It is calculated by dividing a stock's price per share by its book value per share. The result is based upon a weighted average of the securities held in the fund.
P/E Ratio - Is the weighted average of each holding's P/E ratio (price of a stock divided by its earnings per share). The result is based upon a weighted average of the securities held in the fund.
Weighted Average Market Cap - The average market capitalization of all companies held in the portfolio with each company weighted according to its percent held in the portfolio. The result is based upon a weighted average of the securities held in the fund.
Contributors & Detractors as of 06/30/2021
Contributors
| Holding | Contribution |
|---|---|
| Calix Inc | 0.8% |
| Shockwave Med Inc | 0.7% |
| Sprout Social Inc | 0.7% |
| Celsius Holdings Inc | 0.7% |
| Raven Industries Inc | 0.6% |
Detractors
| Holding | Contribution |
|---|---|
| Viant Technology Inc | -0.6% |
| Scholar Rock Holding Corp | -0.5% |
| Sleep Number Corp | -0.5% |
| Magnite Inc | -0.5% |
| Orchard Therapeutics Pl | -0.5% |
% Contribution reflects the effect of the individual stock's performance on the Fund's overall performance for the period. Individual holdings and their effect on Fund performance may change significantly over time. Investors should consider the overall performance of the Fund before making a decision on whether or not to invest in the Fund.
Attribution Analysis
| Micro Cap Growth Fund | Benchmark | Variance | |||||
|---|---|---|---|---|---|---|---|
| Sector | Avg. Weight | Base Return | Avg. Weight | Base Return | Stock Selection | Group Weight | Total |
The total base return displayed for the Fund does not capture daily cash flow and trading activity and therefore is subject to reasonable variance from the Fund's actual return. Please refer to the Fund's performance results for longer-term returns. The Fund is actively managed and portfolio characteristics, such as individual holdings and sector weightings, may change significantly over time.
Source: Wilshire Attribution Software. GICS sector classification; non-GICS securities classified by Lord Abbett. Sectors may include many industries.
Dividends & Cap Gains
Dividends & Cap Gains
Dividend Payments
- YTD Dividends Paidas of 09/22/2021
- $0
- Dividend Frequency
- Annually
| Record Date | Ex-Dividend Date | Reinvest & Payable Date | Dividend | Reinvest Price |
|---|---|---|---|---|
| 11/20/2001 | 11/21/2001 | 11/21/2001 | $0.00740 | $10.09 |
Upcoming Dividend Payment Dates
This section lists all anticipated Income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.
| Record Date | Ex-Dividend Date | Reinvest & Payable Date |
|---|---|---|
| 11/22/2021 | 11/23/2021 | 11/23/2021 |
Capital Gains Distributions
| Record Date | Reinvest & Payable Date | Long-term | Short-term * | Total | Reinvest Price |
|---|---|---|---|---|---|
| 11/23/2020 | 11/24/2020 | $2.8043 | $2.2741 | $5.0784 | $15.43 |
Taxed as ordinary income
Lord Abbett does not provide tax advice. It is strongly recommended that you discuss the impact of dividends and distributions with your tax advisor.
Upcoming Capital Gain Distribution
This section lists all anticipated Income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.
| Record Date | Ex-Dividend Date |
|---|---|
| 11/22/2021 | 11/23/2021 |
Fees & Expenses
Fees & Expenses
Sales Charge Schedule as of 09/22/2021
| Sales Charge | Dealer's Concession | Prices at Breakpoint | |
|---|---|---|---|
| Less than $50,000 | 5.75% | 5.00% | $19.79 |
| $50,000 to $99,999 | 4.75% | 4.00% | $19.58 |
| $100,000 to $249,999 | 3.95% | 3.25% | $19.42 |
| $250,000 to $499,999 | 2.75% | 2.25% | $19.18 |
| $500,000 to $999,999 | 1.95% | 1.75% | $19.02 |
| $1,000,000 to $5,000,000 | 0.00% | 1.00% | $18.65 |
The 12b-1 trail commission is 0.15% (accrues immediately) for all fixed-income and municipal income funds.
Class A shares purchased without a sales charge (commissionable NAV) will be subject to a CDSC of 1% if they are redeemed before the first day of the month in which the one-year anniversary of the purchase falls.
Expense Ratioas of 08/31/2021
| 1.33% |
Fund Documents
Fund Documents
Download fund documents & literature, create email subscriptions, and place direct mail order
|
0Documents selected
|
Order | ||||
|---|---|---|---|---|---|
| n/a |
Portfolio Holdings 1Q
Publish Date:11/03/2015
|
||||
| n/a |
Portfolio Holdings 3Q
Publish Date:11/03/2015
|
||||
|
Summary Prospectus
Publish Date:11/03/2015
|
|||||
| n/a |
Statutory Prospectus
Publish Date:11/03/2015
|
||||
| n/a |
Prospectus (XBRL)
Publish Date:11/03/2015
|
||||
|
SAI
Publish Date:11/03/2015
|
|||||
|
Annual Report
Publish Date:11/03/2015
|
|||||
|
Semi-Annual Report
Publish Date:11/03/2015
|
|||||
|
Fact Sheet
Publish Date:11/03/2015
|
|||||